-
Three more US states announce lawsuits against Purdue
europeanpharmaceuticalreview
June 11, 2019
A total of 48 US states are now suing Purdue Pharma, claiming they falsely marketed their opioid drug.
-
Symbiosis Boosts Business Development Team to Support US Growth
contractpharma
June 10, 2019
Helen Caddy-Leach to lead the Scottish CMO’s push into the U.S.
-
First treatment for cluster headaches approved in US
europeanpharmaceuticalreview
June 10, 2019
The FDA has given its approval to a new injection for cluster headaches which reduce frequency of attacks.
-
CDC: Reported Measles Cases Reach 971
drugs
June 03, 2019
Reported Measles Cases Reach 971.
-
2007 to 2017 Saw Decline in Number of U.S. Pathologists
drugs
June 03, 2019
2007 to 2017 Saw Decline in Number of U.S. Pathologists.
-
High Costs Associated With Physician Burnout in U.S.
drugs
May 31, 2019
High Costs Associated With Physician Burnout in U.S.
-
U.S. Dentists Prescribe Opioids More Often Than U.K. Dentists
drugs
May 31, 2019
U.S. Dentists Prescribe Opioids More Often Than U.K. Dentists.
-
Inhibrx Announces Agreement for INBRX-101 outside US, Canada with Chiesi Group
americanpharmaceuticalreview
May 31, 2019
Inhibrx has entered into an agreement with Chiesi Farmaceutici. The agreement grants Chiesi Group an option to exclusively license, develop and commercialize INBRX-101 outside of ...
-
Zydus Cadila gets USFDA nod for acid reflux drug
expressbpd
May 24, 2019
The drug, esomeprazole, belongs to the group of medicines termed as proton pump inhibitors and reduces the amount of acid secreted by the stomach
-
US incident cases of Hepatitis A increase by 294% in 2016–2018 from 2013–2015
pharmaceutical-technology
May 23, 2019
Hepatitis A is a virus that is primarily transmitted via the faecal-oral route after close contact with an infected person. It is the most common cause of viral hepatitis globally; symptoms tend to be acute and self-limiting, but the disease rarely can ca